Halliburton (NYSE:HAL) has entered into a strategic collaboration agreement with PETRONAS Suriname Exploration & Production BV and Valaris to accelerate the development of offshore assets in Suriname through an integrated, early-lifecycle engagement model.
Oracle (NYSE:ORCL) has named Hilary Maxson as its new Chief Financial Officer, effective April 6, 2026, placing a veteran of capital-intensive industries at the helm of its finance organization during the most significant infrastructure expansion in the company's history.
Medicus Pharma (NASDAQ:MDCX) has reached a critical regulatory milestone, submitting an optimized Phase 2 clinical trial protocol to the U.S. Food and Drug Administration (FDA) for its lead candidate, Teverelix, aimed at preventing recurrent acute urinary retention (AURr) in men with benign prostatic hyperplasia (BPH).
Capstone Holding (NASDAQ:CAPS), a tech-enabled building products distribution platform, has secured a significant expansion of its portfolio through a new distribution agreement for Eldorado Stone, a premium manufactured stone veneer brand from Westlake Royal Building Products.
Hillman Solutions (NASDAQ:HLMN), a leading provider of hardware and home improvement solutions, has completed the acquisition of Campbell Chain & Fittings from Apex Tool Group, a move that significantly broadens the company’s industrial Maintenance, Repair, and Operations (MRO) portfolio.
DeFi Technologies (NASDAQ:DEFT) reported record-breaking financial results for the fiscal year ended December 31, 2025, as the firm’s diversified digital asset strategy and recent acquisitions drove a significant expansion in both top-line revenue and net profitability.
Sharps Technology (NASDAQ:STSS) has reported its 2025 year-end results, revealing a comprehensive structural transformation from a medical device manufacturer into a digital asset-focused treasury holding company centered on the Solana ecosystem.
Sagimet Biosciences (NASDAQ:SGMT) announced today that it will present updated results from its Phase 2b FASCINATE-2 clinical trial at the Fueling MASH Keystone Symposium, held April 12-15, 2026, in Vancouver, British Columbia.
NRx Pharmaceuticals (NASDAQ:NRXP) moved a step closer to commercializing its generic preservative-free ketamine today, announcing that the FDA’s Office of Generic Drugs has provided preliminary alignment on the product's labeling.
Neurocrine Biosciences (NASDAQ:NBIX) announced today a definitive agreement to acquire Soleno for $53 per share in an all-cash transaction valued at approximately $2.9 billion, significantly broadening its commercial portfolio in the rare disease and endocrinology sectors.
Playtika Holding (NASDAQ:PLTK), a global leader in mobile gaming and entertainment, announced on April 6, 2026, that its Board of Directors has initiated a formal process to explore strategic alternatives for the company.
Miami International Holdings (NYSE:MIAX) reported record-breaking trading results for March 2026, as the exchange operator continues to capture a larger slice of the U.S. options and equities markets through the first quarter of the year.
